PPARG and atrial fibrillation: Pioglitazone, a PPAR-γ activator, significantly reduced AF duration in aged rats to 45.6 ± 10.5 seconds (young, 30.7 ± 7.3 second; aged, 107.4 ± 24.2 second) [32].